Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients

Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

(2014) Christopher D. Buckley et al.   IMMUNITY

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

(2014) Eric G. Meissner et al.   JOURNAL OF CLINICAL INVESTIGATION

Failing FXR expression in the liver links aging to hepatic steatosis

(2014) Philippe Lefebvre et al.   JOURNAL OF HEPATOLOGY

Forkhead Box Transcription Factor Regulation and Lipid Accumulation by Hepatitis C Virus

(2014) S. K. Bose et al.   JOURNAL OF VIROLOGY

Is genotype 3 of the hepatitis C virus the new villain?

(2013) Nicolas Goossens et al.   HEPATOLOGY

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

(2013) Anuoluwapo Osinusi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin

(2013) Eric G. Meissner et al.   JOURNAL OF INFECTIOUS DISEASES

Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expressionin vivoandin vitro

(2013) Á. Rojas et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?

(2013) F.-K. F. Cheng et al.   JOURNAL OF VIRAL HEPATITIS

Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots

(2013) K-L. Milner et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C Virus Stimulates Low-Density Lipoprotein Receptor Expression To Facilitate Viral Propagation

(2013) G. H. Syed et al.   JOURNAL OF VIROLOGY

Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly

(2013) Qisheng Li et al.   NATURE MEDICINE

HCV causes systemic disorders that can be cured

(2013) Francesco Negro   Nature Reviews Gastroenterology & Hepatology

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection

(2013) Ralf Bartenschlager et al.   NATURE REVIEWS MICROBIOLOGY

Lipid mediators in immune dysfunction after severe inflammation

(2013) James N. Fullerton et al.   TRENDS IN IMMUNOLOGY

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

(2013) Daniel Felmlee et al.   Viruses-Basel

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

(2013) Dragana Nikolic et al.   Nutrients

Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C

(2012) Salvatore Petta et al.   Clinical Gastroenterology and Hepatology

HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?

(2012) Francesco Negro   GASTROENTEROLOGY

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1

(2012) Lawrence Serfaty et al.   GUT

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

(2012) Hung-Yu Sun et al.   GUT

Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b

(2012) Masanori Atsukawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)

(2012) David A. Sheridan et al.   Clinics and Research in Hepatology and Gastroenterology

Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis

(2011) J. Rowell et al.   Hepatology International

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

(2011) Hans L. Tillmann et al.   JOURNAL OF HEPATOLOGY

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis

(2011) Pierre Deltenre et al.   JOURNAL OF HEPATOLOGY

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C

(2010) Gowtham A. Rao et al.   GASTROENTEROLOGY

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

(2010) Stephen A. Harrison et al.   HEPATOLOGY

Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver

(2010) Tatsuya Fujino et al.   HEPATOLOGY RESEARCH

Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome

(2010) Andreas Merz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and Differences

(2010) C. Yu et al.   JOURNAL OF VIROLOGY

Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up

(2009) Kathleen E. Corey et al.   HEPATOLOGY

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis

(2008) Ming-Ling Chang et al.   BMC GENOMICS

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

(2008) J. Sierra-Johnson et al.   EUROPEAN HEART JOURNAL